Assessment of complications due to intratympanic injections

Objective: The purpose of the study is to report and to analyze the complications following intratympanic injections (ITI) of steroids. The occurrence rate of complications at different ITI sites, four quadrants of eardrum, was also compared. Methods: A retrospective clinical review in a medical cen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu-Chuan Liu, Fan-Hsiang Chi, Ting-Hua Yang, Tien-Chen Liu
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2016
Materias:
Acceso en línea:https://doaj.org/article/116948afadd64285b32e0cb4d4feeed5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:116948afadd64285b32e0cb4d4feeed5
record_format dspace
spelling oai:doaj.org-article:116948afadd64285b32e0cb4d4feeed52021-12-02T12:57:43ZAssessment of complications due to intratympanic injections2095-881110.1016/j.wjorl.2015.11.001https://doaj.org/article/116948afadd64285b32e0cb4d4feeed52016-03-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095881115300172https://doaj.org/toc/2095-8811Objective: The purpose of the study is to report and to analyze the complications following intratympanic injections (ITI) of steroids. The occurrence rate of complications at different ITI sites, four quadrants of eardrum, was also compared. Methods: A retrospective clinical review in a medical center. Each patient received ITI twice in a week for 2â3 consecutive weeks as a salvage therapy for sudden sensorineural hearing loss. Post-injection complications, especially transient dizziness and vertigo, were recorded. Patients with acute or chronic vertigo episodes in 1 month were excluded. Results: A total of 59 patients with sudden sensorineural hearing loss and a total of 278 times of ITI were performed in 1 year. The post-injection complications included pain, tongue numbness, transient dizziness, vertigo, tinnitus, and a small persistent perforation. There was no significant difference in the occurrence of these complications between the injections sites on the 4 quadrants of the tympanic membrane. However, there was statistical significance in the post-injection vertiginous episode after IT injections to posterior-inferior quadrant (Q3) and posterior-superior quadrant (Q4) compared to anterior-superior quadrant (Q1) and anterior-inferior quadrant (Q2) (P = 0.0113). Conclusion: IT injection is recommended to be applied to the Q2 since the Q1 and Q4 injections are more likely to induce the adverse effect of tongue numbness, while the Q3 and Q4 areas are more likely to induce post-injection vertigo. Keywords: Intratympanic injection, Sudden deafness, Complications, VertigoYu-Chuan LiuFan-Hsiang ChiTing-Hua YangTien-Chen LiuKeAi Communications Co., Ltd.articleOtorhinolaryngologyRF1-547SurgeryRD1-811ENWorld Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 2, Iss 1, Pp 13-16 (2016)
institution DOAJ
collection DOAJ
language EN
topic Otorhinolaryngology
RF1-547
Surgery
RD1-811
spellingShingle Otorhinolaryngology
RF1-547
Surgery
RD1-811
Yu-Chuan Liu
Fan-Hsiang Chi
Ting-Hua Yang
Tien-Chen Liu
Assessment of complications due to intratympanic injections
description Objective: The purpose of the study is to report and to analyze the complications following intratympanic injections (ITI) of steroids. The occurrence rate of complications at different ITI sites, four quadrants of eardrum, was also compared. Methods: A retrospective clinical review in a medical center. Each patient received ITI twice in a week for 2â3 consecutive weeks as a salvage therapy for sudden sensorineural hearing loss. Post-injection complications, especially transient dizziness and vertigo, were recorded. Patients with acute or chronic vertigo episodes in 1 month were excluded. Results: A total of 59 patients with sudden sensorineural hearing loss and a total of 278 times of ITI were performed in 1 year. The post-injection complications included pain, tongue numbness, transient dizziness, vertigo, tinnitus, and a small persistent perforation. There was no significant difference in the occurrence of these complications between the injections sites on the 4 quadrants of the tympanic membrane. However, there was statistical significance in the post-injection vertiginous episode after IT injections to posterior-inferior quadrant (Q3) and posterior-superior quadrant (Q4) compared to anterior-superior quadrant (Q1) and anterior-inferior quadrant (Q2) (P = 0.0113). Conclusion: IT injection is recommended to be applied to the Q2 since the Q1 and Q4 injections are more likely to induce the adverse effect of tongue numbness, while the Q3 and Q4 areas are more likely to induce post-injection vertigo. Keywords: Intratympanic injection, Sudden deafness, Complications, Vertigo
format article
author Yu-Chuan Liu
Fan-Hsiang Chi
Ting-Hua Yang
Tien-Chen Liu
author_facet Yu-Chuan Liu
Fan-Hsiang Chi
Ting-Hua Yang
Tien-Chen Liu
author_sort Yu-Chuan Liu
title Assessment of complications due to intratympanic injections
title_short Assessment of complications due to intratympanic injections
title_full Assessment of complications due to intratympanic injections
title_fullStr Assessment of complications due to intratympanic injections
title_full_unstemmed Assessment of complications due to intratympanic injections
title_sort assessment of complications due to intratympanic injections
publisher KeAi Communications Co., Ltd.
publishDate 2016
url https://doaj.org/article/116948afadd64285b32e0cb4d4feeed5
work_keys_str_mv AT yuchuanliu assessmentofcomplicationsduetointratympanicinjections
AT fanhsiangchi assessmentofcomplicationsduetointratympanicinjections
AT tinghuayang assessmentofcomplicationsduetointratympanicinjections
AT tienchenliu assessmentofcomplicationsduetointratympanicinjections
_version_ 1718393549555236864